TY - JOUR
T1 - Enhanced external counterpulsation improves exercise duration and peak oxygen consumption in older patients with heart failure
T2 - a subgroup analysis of the PEECH trial.
AU - Abbottsmith, Charles W.
AU - Chung, Eugene S.
AU - Varricchione, Thomas
AU - de Lame, Paul Andre
AU - Silver, Marc A.
AU - Francis, Gary S.
AU - Feldman, Arthur M.
PY - 2006
Y1 - 2006
N2 - The Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure (PEECH) trial demonstrated that enhanced external counterpulsation (EECP) therapy increased exercise duration and improved functional status and quality of life without affecting peak oxygen consumption. The authors present data from a prespecified subgroup of elderly patients (65 years or older) enrolled in the PEECH trial. The 2 co-primary end points were the percentage of subjects with a >60-second increase in exercise duration and the percentage of subjects with a >1.25-mL/kg/min increase in peak volume of oxygen consumption. At 6-month follow-up, the exercise responder rate was significantly higher in EECP patients compared with controls (P=.008). Further, in contrast to the overall PEECH study, the EECP group demonstrated a significantly higher responder rate for peak oxygen consumption (P=.017). The authors conclude that an older subgroup of PEECH subjects confirms the beneficial effect of EECP in patients with chronic, stable, mild-to-moderate heart failure.
AB - The Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart Failure (PEECH) trial demonstrated that enhanced external counterpulsation (EECP) therapy increased exercise duration and improved functional status and quality of life without affecting peak oxygen consumption. The authors present data from a prespecified subgroup of elderly patients (65 years or older) enrolled in the PEECH trial. The 2 co-primary end points were the percentage of subjects with a >60-second increase in exercise duration and the percentage of subjects with a >1.25-mL/kg/min increase in peak volume of oxygen consumption. At 6-month follow-up, the exercise responder rate was significantly higher in EECP patients compared with controls (P=.008). Further, in contrast to the overall PEECH study, the EECP group demonstrated a significantly higher responder rate for peak oxygen consumption (P=.017). The authors conclude that an older subgroup of PEECH subjects confirms the beneficial effect of EECP in patients with chronic, stable, mild-to-moderate heart failure.
UR - http://www.scopus.com/inward/record.url?scp=39049181248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=39049181248&partnerID=8YFLogxK
U2 - 10.1111/j.1527-5299.2006.05904.x
DO - 10.1111/j.1527-5299.2006.05904.x
M3 - Article
C2 - 17170583
AN - SCOPUS:39049181248
SN - 1527-5299
VL - 12
SP - 307
EP - 311
JO - Congestive heart failure (Greenwich, Conn.)
JF - Congestive heart failure (Greenwich, Conn.)
IS - 6
ER -